Equillium, Inc.(EQ)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Equillium, Inc. (EQ) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EQ at 11.7/100 on a 32-signal composite quality model, placing it at rank #2,900 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (1.6) and balance sheet strength (3.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 23.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Equillium, Inc. reports net income of $-4.7M, free cash flow of $-4.2M. Top institutional holders of EQ by reported 13-F value include Jupiter Topco, Decheng Capital, Affinity Asset Advisors, based on the most recent SEC filings. EQ trades on the Nasdaq exchange and files with the SEC under CIK 1746466. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EQ daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Equillium, Inc. directly from SEC EDGAR.